Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

2.

The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation, Russian Academy of Medical Science.

Washington (DC): National Academies Press (US); 2011.

3.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
4.
5.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

6.

Size and usage patterns of private TB drug markets in the high burden countries.

Wells WA, Ge CF, Patel N, Oh T, Gardiner E, Kimerling ME.

PLoS One. 2011 May 4;6(5):e18964. doi: 10.1371/journal.pone.0018964.

7.

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.

Sachdeva KS, Raizada N, Gupta RS, Nair SA, Denkinger C, Paramasivan CN, Kulsange S, Thakur R, Dewan P, Boehme C, Arinaminpathy N.

PLoS One. 2015 Jul 1;10(7):e0131438. doi: 10.1371/journal.pone.0131438. eCollection 2015.

8.

The making of a public health problem: multi-drug resistant tuberculosis in India.

Engel NC.

Health Policy Plan. 2013 Jul;28(4):375-85. doi: 10.1093/heapol/czs069. Epub 2012 Aug 3.

9.

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, Ladomirska J, Sotgiu G, Migliori GB, Pontali E, Saranchuk P, Rodrigues C, Reid T.

PLoS One. 2011;6(12):e28066. doi: 10.1371/journal.pone.0028066. Epub 2011 Dec 1.

10.

Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.

Isaakidis P, Das M, Kumar AM, Peskett C, Khetarpal M, Bamne A, Adsul B, Manglani M, Sachdeva KS, Parmar M, Kanchar A, Rewari BB, Deshpande A, Rodrigues C, Shetty A, Rebello L, Saranchuk P.

PLoS One. 2014 Oct 21;9(10):e110461. doi: 10.1371/journal.pone.0110461. eCollection 2014.

11.

The burden of MDR/XDR tuberculosis in coastal plains population of China.

Yang X, Yuan Y, Pang Y, Wang B, Bai Y, Wang Y, Yu B, Zhang Z, Fan M, Zhao Y.

PLoS One. 2015 Feb 17;10(2):e0117361. doi: 10.1371/journal.pone.0117361. eCollection 2015.

12.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
13.

Disease control implications of India's changing multi-drug resistant tuberculosis epidemic.

Suen SC, Bendavid E, Goldhaber-Fiebert JD.

PLoS One. 2014 Mar 7;9(3):e89822. doi: 10.1371/journal.pone.0089822. eCollection 2014.

14.

Drug-resistant tuberculosis: past, present, future.

Chiang CY, Centis R, Migliori GB.

Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Review.

PMID:
20337989
15.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
16.

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS: Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences.

Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Feb 28.

17.
18.

[Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].

Li J, Zhang YY, Gui XH, Yuan ZA, Pan QC, Mei J, Shen X.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):796-8. Chinese.

PMID:
22967331
19.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

20.

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.

Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, Simpson J, Barnard M, Coetzee G, van Cutsem G, Goemaere E.

PLoS One. 2010 Nov 15;5(11):e13901. doi: 10.1371/journal.pone.0013901.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk